STOCK TITAN

Neurogene: Jennison reports 11.1% ownership stake

Jennison reported sole voting power and shared dispositive power over the reported position.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Neurogene Inc. common stock ownership reported by Jennison Associates LLC totaled 2,229,082 shares, or 11.1% of the class, as of September 30, 2026. Beata Markowicz, Senior Vice President, Compliance, signed for Jennison Associates LLC.

Beneficially owned 2,229,082 shares Neurogene common stock as of September 30, 2026
Percent of class 11.1% Neurogene common stock as of September 30, 2026
Sole voting power 2,229,082 shares Reported by Jennison Associates LLC
Shared dispositive power 2,229,082 shares Reported by Jennison Associates LLC
beneficially owned financial
"Amount beneficially owned: 2229082"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole power to vote or to direct the vote financial
"Sole power to vote or to direct the vote: 2229082"
Shared power to dispose or to direct the disposition of financial
"Shared power to dispose or to direct the disposition of: 2229082"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NGNE shares did Jennison Associates report owning?

Jennison Associates LLC reported beneficial ownership of 2,229,082 Neurogene common shares, equal to 11.1% of the class as of September 30, 2026.

What voting and disposition powers did Jennison Associates report over NGNE shares?

Jennison Associates LLC reported sole voting power over 2,229,082 shares and shared dispositive power over 2,229,082 shares. It reported no sole dispositive power and no shared voting power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





64135M105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Jennison Associates LLC
Signature:Beata Markowicz
Name/Title:Senior Vice President, Compliance
Date:10/06/2026

Keep reading